《盈警響號》理士國際(00842.HK)料上半年純利收窄至500萬至1,500萬人幣
理士國際(00842.HK)公布,預計截至今年6月30日止六個月集團將錄得微薄的淨利潤,範圍在500萬元人民幣(下同)至1,500萬元之間,而去年同期7,869.3萬元。
集團指,儘管全球爆發新型肺炎大流行,集團於期間的電池及相關項目業務收入仍錄得輕微增長。然而,集團的再生鉛廠在大部分中期期間都受到生產中斷的影響,生產只能在5月下旬恢復,導致集團營業額整體下降4%至8%。集團淨利潤下降主要是由於疫情預防和控制政策擾亂了集團的全球業務,導致利潤貢獻減少;與對上財年中期相比缺乏其他收入和收益,對上財年中期錄得出售子公司的收益約4,200萬元;人民幣兌美元貶值產生的匯兌淨損失。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.